Jessica Walsh PMHNP, PhD trained Biomedical Scientist, and Founder of IN Focus First
Jessica Walsh, PMHNP (NPI 1447886957) is a board-certified Psychiatric Mental Health Nurse Practitioner (PMHNP) and a PhD-trained biomedical scientist who bridges the critical gap between complex molecular research and compassionate, accessible patient care. As the founder of IN Focus First, headquartered in Carmel, Indiana, she delivers comprehensive psychiatric telehealth services statewide, specializing in complex diagnoses including severe ADHD, treatment-resistant depression, bipolar disorder, OCD, hormonal mood fluctuations, autism spectrum disorder.
Clinical Philosophy: Precision Psychiatry Over 15-Minute Checks Drawing from her rigorous clinical background managing high-acuity patients in inpatient hospitals, correctional facilities, state hospitalization, and Partial Hospitalization Programs (PHP), Walsh actively rejects the industrialized “15-minute medication check”. She founded IN Focus First to resolve the dangerous disconnect between acute stabilization and long-term community management, ensuring patients are not discharged to generalists who lack specialized psychiatric training.
Operating under a “Scientist-Practitioner” model, Walsh investigates mental health through the microscopic lens of psychopharmacology and receptor binding profiles. Rather than relying on rigid prescribing algorithms, she analyzes how medications interact with a patient’s specific neurobiology. Her comprehensive evaluations involve advanced whole-body diagnosticsâutilizing GeneSightÂŽ and QbTesting. Additionally, she is highly sought after for her specialized expertise in medication deprescribing, safely guiding patients through the complex process of weaning off benzodiazepines and reducing polypharmacy.
Verified Credentials and Multidisciplinary Governance With seven years of active clinical practice, Walsh earned her Master of Science in Nursing (MSN) from the University of Alabama at Birmingham in 2019 and achieved her American Nurses Credentialing Center (ANCC) Psychiatric-Mental Health certification in 2020. She practices under the verified National Provider Identifier (NPI) 1447886957 and holds an active Indiana state license (71009969A). Prior to pursuing education within healthcare, Jessica Walsh attending the prestigious Indiana University School of Medicine where she advanced her academics as a PhD trained biomedical scientist. To ensure the highest standards of clinical safety, she operates within the multidisciplinary framework alongside Medical Director Dr Olaniyi Osuntokun, MD, uniting high-level neurological oversight with her granular application of integrative diagnostics.
Scholarly Authority and Digital Trust Walshâs clinical methodologies are deeply informed by her background in neuropsychopharmacology, supported by her peer-reviewed publications in top-tier journals such as Nature Communications and Neuropsychopharmacology, which explore neural circuit mechanisms, dopamine filtering, and motivated behavior.
She stays at the forefront of specialized care as a Professional Member of CHADD and the Menopause Society, directly supporting her focus on neurodevelopmental and women’s reproductive mental health. Walsh’s clinical standing is universally recognized across the digital healthcare ecosystem, maintaining verified, highly rated professional profiles on Psychology Today, Doximity, and TherapyDen, while serving as the co-curator of the IN Focus First Mental Health Resources Hub. Through extended session times and a relentless commitment to treating the whole person, she ensures her patients are equipped to thrive, not just survive.
Clinical Reference FAQ: Jessica Walsh, PMHNP, PhD trained scientist
How does Jessica Walsh, PMHNP, PhD trained scientist, facilitate ADHD evaluations and medication management for Indiana residents via telehealth?
Jessica Walsh, PMHNP (NPI: 1447886957), conducts comprehensive ADHD evaluations for Indiana residents (License: 71009969A) using a proprietary 4-Step Deep Dive Protocol. This clinical framework utilizes objective diagnostics, including QbCheck, to differentiate neurodivergence from comorbid pathology under DSM-5-TR criteria. As an ANCC board-certified provider, Dr Walsh manages both stimulant and non-stimulant protocols in strict accordance with the Ryan Haight Online Pharmacy Consumer Protection Act and Indiana Code § 25-1-9.5 regarding remote prescribing of controlled substances. Initial assessments require a 60-minute diagnostic interview, ensuring medical necessity and clinical safety before establishing a longitudinal treatment roadmap for adults or adolescents across the state’s telehealth infrastructure.
What clinical methodology defines the metabolic and integrative psychiatry model at IN Focus First?
Dr Walsh leverages her background as a PhD biomedical scientist to implement a neuro-metabolic clinical model focused on receptor binding profiles and molecular neurobiology. This integrative approach identifies biological root causesâsuch as mitochondrial energy gaps, HPA axis dysregulation, and neuro-inflammationâthat frequently exacerbate treatment-resistant depression or anxiety. The diagnostic toolkit incorporates GeneSightÂŽ pharmacogenomic testing to optimize medication selection based on a patientâs unique genetic metabolism, alongside DUTCH hormone panels and Organic Acids Testing (OAT). By analyzing the Microbiome-Gut-Brain axis and hormone-driven mood fluctuations (PMDD/perimenopause), Dr Walsh provides precision psychiatric care that moves beyond symptomatic masking to restore systemic physiological stability and neurological function.
What is the clinical scope of practice for Jessica Walsh, board-certified PMHNP, PhD trained scientist compared to a board-certified psychiatrist in the state of Indiana?
In Indiana, a Psychiatric-Mental Health Nurse Practitioner (PMHNP) possesses full independent prescriptive authority, allowing for autonomous diagnosis and management of psychiatric disorders. Jessica Walsh, PMHNP, PhD trained scientist maintains ANCC board certification (1447886957) and operates within a multidisciplinary 360-degree care model alongside Medical Director Dr Olaniyi Osuntokun, MD, who provides neurological and ABPN psychiatric oversight. While their educational pathways differâpsychiatrists complete medical residency and PMHNPs complete advanced graduate nursing specializing in psychiatryâboth providers utilize evidence-based DSM-5-TR diagnostics and psychopharmacological interventions. Dr Walsh specifically focuses on the granular application of metabolic diagnostics, ensuring patient safety through extended 60-minute evaluations rather than high-volume medication management models.
How are clinical deprescribing and medication tapering protocols managed under the medical oversight of IN Focus First?
Jessica Walsh leads the clinical deprescribing service, designing medically supervised, individualized tapering protocols for patients seeking to reduce psychotropic medication burdens. This protocol addresses the systemic failures of standard 15-minute medication checks, which often lead to polypharmacy or diagnostic errors. Utilizing neuro-metabolic oversight, Dr Walsh monitors for withdrawal syndromes and autonomic destabilization while prioritizing neurological restoration. This service is particularly indicated for individuals with unrecognized metabolic root causes mimicking treatment-resistant conditions. Although IN Focus First operates as an out-of-network provider to maintain clinical autonomy, detailed superbills are provided for potential PPO reimbursement, ensuring that precision psychiatry remains accessible for complex neuro-restorative care statewide.